Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Enterobacteriaceae

ABSTRACT: Escherichia coli and Escherichia marmotae - Tunisia - Meriem

PROVIDER: PRJNA976065 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR24834200_1.fastq.gz	Fastqsanger.gz
	SRR24834200_2.fastq.gz	Fastqsanger.gz
	SRR24834201_1.fastq.gz	Fastqsanger.gz
	SRR24834201_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 87

Similar Datasets

Enterobacteriaceae

Project description:Genome sequencing and assembly: Moellerella wisconsensis and Escherichia marmotae

| PRJNA814053 | ENA

Enterobacteriaceae

Project description:Escherichia coli, Klebsiella pneumoniae Genome sequencing

| PRJNA261775 | ENA

Enterobacteriaceae

Project description:Carbapenem resistant Escherichia coli among farms

| PRJNA349231 | ENA

Enterobacteriaceae

Project description:PulseNet Escherichia coli and Shigella genome sequencing

| PRJNA218110 | ENA

Project description:Escherichia marmotae

| PRJNA1328070 | ENA

Study for investigating the effects of a probiotic on diarrhea caused by chemotherapy in patients with gastric, colon and rectum cancer

Project description:Primary objectives: The study investigates whether a Escherichia coli Nissle-suspenison has a (preventive) antidiarrheal effect in patients with tumors who are treated with chemotherapeutic schemes which are associated with increased occurances of diarrhea. Diarrhea caused by treatment are thought to be reduced in intensity and/or frequency by the treatment with Escherichia coli Nissle-Suspension. Primary endpoints: Common toxicity criteria (CTC) for diarrhea

| 2534265 | ecrin-mdr-crc

Enterobacteriaceae

Project description:Escherichia coli and Klebsiella pneumoniae multidrug-resistant Raw sequence reads

| PRJNA523709 | ENA

Discovery and AI-guided mechanistic elucidation of a novel Enterobacteriaceae-specific antibiotic

Project description:Current clinical antibiotics are largely broad-spectrum agents that promote intestinal dysbiosis and colonisation of Enterobacteriaceae, which are often drug-resistant. Indeed, dysbiosis creates an ideal niche for adherent-invasive Escherichia coli (AIEC) in patients with inflammatory bowel disease (IBD). There is an urgent and unmet need for novel narrow-spectrum and microbiome-sparing antibiotics. Here, we screened >10,000 molecules for antibacterial activity against AIEC and discovered enterololin, an antibacterial compound with targeted activity against Enterobacteriaceae species. Molecular substructure- and deep learning-guided mechanism of action investigations revealed that enterololin perturbs lipoprotein trafficking through a mechanism involving the LolCDE complex. Moreover, enterololin can suppress an AIEC infection in mouse models, while largely preserving the overall microbiome composition. This work highlights the utility of deep learning methods for predicting molecular interactions, thereby accelerating mechanism of action elucidation of novel molecules, and identifies a promising Enterobacteriaceae-specific antibacterial candidate for further development to treat challenging infections in IBD patients.

2025-08-27 | GSE300731 | GEO

Escherichia marmotae strain:E690

Project description:Escherichia marmotae E690

| PRJNA632731 | ENA

Escherichia marmotae

Project description:Escherichia marmotae overview

| PRJNA429864 | ENA